Annual report
2590.TEDINET S100VMJ0
Period2024-01-21 → 2025-01-20
Filed2025-04-16
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥237.2bn | 2024-01-21 → 2025-01-20 | Cons. | Net sales |
| Revenue | ¥213.4bn | 2023-01-21 → 2024-01-20 | Cons. | Net sales |
| Revenue | ¥160.1bn | 2022-01-21 → 2023-01-20d | Cons. | Net sales (5-year summary) |
| Revenue | ¥162.6bn | 2021-01-21 → 2022-01-20d | Cons. | Net sales (5-year summary) |
| Revenue | ¥158.2bn | 2020-01-21 → 2021-01-20d | Cons. | Net sales (5-year summary) |
| Operating income | ¥4.8bn | 2024-01-21 → 2025-01-20 | Cons. | Operating income |
| Operating income | ¥3.7bn | 2023-01-21 → 2024-01-20 | Cons. | Operating income |
| Ordinary income | ¥3.0bn | 2024-01-21 → 2025-01-20 | Cons. | Ordinary income |
| Ordinary income | ¥3.1bn | 2023-01-21 → 2024-01-20 | Cons. | Ordinary income |
| Ordinary income | ¥591m | 2022-01-21 → 2023-01-20d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.7bn | 2021-01-21 → 2022-01-20d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.7bn | 2020-01-21 → 2021-01-20d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥7.9bn | 2024-01-21 → 2025-01-20 | Cons. | Income before income taxes |
| Profit before tax | ¥5.6bn | 2023-01-21 → 2024-01-20 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.8bn | 2024-01-21 → 2025-01-20 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.4bn | 2023-01-21 → 2024-01-20 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥507m | 2022-01-21 → 2023-01-20d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥4.0bn | 2021-01-21 → 2022-01-20d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.2bn | 2020-01-21 → 2021-01-20d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥3.4bn | 2024-01-21 → 2025-01-20 | Cons. | Profit loss |
| Net income | ¥4.6bn | 2023-01-21 → 2024-01-20 | Cons. | Profit loss |
| Total assets | ¥185.2bn | at 2025-01-20 | Cons. | Assets |
| Total assets | ¥177.6bn | at 2024-01-20 | Cons. | Assets |
| Total assets | ¥164.2bn | at 2023-01-20d | Cons. | Total assets (5-year summary) |
| Total assets | ¥159.0bn | at 2022-01-20d | Cons. | Total assets (5-year summary) |
| Total assets | ¥157.6bn | at 2021-01-20d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥91.7bn | at 2025-01-20 | Cons. | Liabilities |
| Total liabilities | ¥86.1bn | at 2024-01-20 | Cons. | Liabilities |
| Net assets / equity | ¥93.5bn | at 2025-01-20 | Cons. | Net assets |
| Net assets / equity | ¥91.5bn | at 2024-01-20 | Cons. | Net assets |
| Net assets / equity | ¥84.1bn | at 2023-01-20d | Cons. | Net assets |
| Net assets / equity | ¥83.3bn | at 2022-01-20d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥82.6bn | at 2021-01-20d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥30.7bn | at 2025-01-20 | Cons. | Cash and deposits |
| Cash and deposits | ¥32.4bn | at 2024-01-20 | Cons. | Cash and deposits |
| Cash & equivalents | ¥29.6bn | at 2025-01-20 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥33.7bn | at 2024-01-20 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.2bn | at 2023-01-20d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥30.1bn | at 2022-01-20d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥32.7bn | at 2021-01-20d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥10.8bn | 2024-01-21 → 2025-01-20 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥9.2bn | 2023-01-21 → 2024-01-20 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.1bn | 2022-01-21 → 2023-01-20d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥8.1bn | 2021-01-21 → 2022-01-20d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥12.5bn | 2020-01-21 → 2021-01-20d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥11.6bn | 2024-01-21 → 2025-01-20 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.2bn | 2023-01-21 → 2024-01-20 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.0bn | 2022-01-21 → 2023-01-20d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.5bn | 2021-01-21 → 2022-01-20d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7.6bn | 2020-01-21 → 2021-01-20d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.7bn | 2024-01-21 → 2025-01-20 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.2bn | 2023-01-21 → 2024-01-20 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.1bn | 2022-01-21 → 2023-01-20d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.7bn | 2021-01-21 → 2022-01-20d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.3bn | 2020-01-21 → 2021-01-20d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥120.66 | 2024-01-21 → 2025-01-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥140.77 | 2023-01-21 → 2024-01-20 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-16.2 | 2022-01-21 → 2023-01-20d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥127.1 | 2021-01-21 → 2022-01-20d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥100.66 | 2020-01-21 → 2021-01-20d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,908.51 | at 2025-01-20 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,843.99 | at 2024-01-20 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,663.79 | at 2023-01-20d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,645.36 | at 2022-01-20d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,612.23 | at 2021-01-20d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 49.6% | at 2025-01-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.4% | at 2024-01-20 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.9% | at 2023-01-20d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.1% | at 2022-01-20d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.8% | at 2021-01-20d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 4.2% | 2024-01-21 → 2025-01-20 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.1% | 2023-01-21 → 2024-01-20 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -0.6% | 2022-01-21 → 2023-01-20d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.8% | 2021-01-21 → 2022-01-20d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.8% | 2020-01-21 → 2021-01-20d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 5,555 | at 2025-01-20 | Cons. | Number of employees |
| Employees | 5,182 | at 2024-01-20 | Cons. | Number of employees |
| Employees | 4,122 | at 2023-01-20d | Cons. | Number of employees |
| Employees | 4,029 | at 2022-01-20d | Cons. | Number of employees |
| Employees | 3,922 | at 2021-01-20d | Cons. | Number of employees |
| Revenue | ¥5.4bn | 2024-01-21 → 2025-01-20 | Standalone | Operating revenue1 |
| Revenue | ¥5.3bn | 2023-01-21 → 2024-01-20 | Standalone | Operating revenue1 |
| Revenue | ¥5.0bn | 2022-01-21 → 2023-01-20d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥4.8bn | 2021-01-21 → 2022-01-20d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥4.8bn | 2020-01-21 → 2021-01-20d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥972m | 2024-01-21 → 2025-01-20 | Standalone | Operating income |
| Operating income | ¥1.1bn | 2023-01-21 → 2024-01-20 | Standalone | Operating income |
| Ordinary income | ¥1.4bn | 2024-01-21 → 2025-01-20 | Standalone | Ordinary income |
| Ordinary income | ¥2.0bn | 2023-01-21 → 2024-01-20 | Standalone | Ordinary income |
| Ordinary income | ¥2.3bn | 2022-01-21 → 2023-01-20d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.4bn | 2021-01-21 → 2022-01-20d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.9bn | 2020-01-21 → 2021-01-20d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.2bn | 2024-01-21 → 2025-01-20 | Standalone | Income before income taxes |
| Profit before tax | ¥4.0bn | 2023-01-21 → 2024-01-20 | Standalone | Income before income taxes |
| Net income | ¥3.1bn | 2024-01-21 → 2025-01-20 | Standalone | Profit loss |
| Net income | ¥2.9bn | 2023-01-21 → 2024-01-20 | Standalone | Profit loss |
| Net income | ¥1.9bn | 2022-01-21 → 2023-01-20d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.4bn | 2021-01-21 → 2022-01-20d | Standalone | Net income loss (5-year summary) |
| Net income | ¥899m | 2020-01-21 → 2021-01-20d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥126.0bn | at 2025-01-20 | Standalone | Assets |
| Total assets | ¥124.8bn | at 2024-01-20 | Standalone | Assets |
| Total assets | ¥122.7bn | at 2023-01-20d | Standalone | Total assets (5-year summary) |
| Total assets | ¥122.2bn | at 2022-01-20d | Standalone | Total assets (5-year summary) |
| Total assets | ¥116.8bn | at 2021-01-20d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥43.3bn | at 2025-01-20 | Standalone | Liabilities |
| Total liabilities | ¥42.4bn | at 2024-01-20 | Standalone | Liabilities |
| Net assets / equity | ¥82.6bn | at 2025-01-20 | Standalone | Net assets |
| Net assets / equity | ¥82.4bn | at 2024-01-20 | Standalone | Net assets |
| Net assets / equity | ¥80.5bn | at 2023-01-20d | Standalone | Net assets |
| Net assets / equity | ¥80.1bn | at 2022-01-20d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥78.5bn | at 2021-01-20d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥21.7bn | at 2025-01-20 | Standalone | Cash and deposits |
| Cash and deposits | ¥25.8bn | at 2024-01-20 | Standalone | Cash and deposits |
| EPS (basic) | ¥98.35 | 2024-01-21 → 2025-01-20 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥92.22 | 2023-01-21 → 2024-01-20 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.07 | 2022-01-21 → 2023-01-20d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.88 | 2021-01-21 → 2022-01-20d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.25 | 2020-01-21 → 2021-01-20d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥40 | 2024-01-21 → 2025-01-20 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2023-01-21 → 2024-01-20 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2022-01-21 → 2023-01-20d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2021-01-21 → 2022-01-20d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2020-01-21 → 2021-01-20d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,614.69 | at 2025-01-20 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,618.07 | at 2024-01-20 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,564.03 | at 2023-01-20d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,559.09 | at 2022-01-20d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,512.97 | at 2021-01-20d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 65.6% | at 2025-01-20 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.0% | at 2024-01-20 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.6% | at 2023-01-20d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.6% | at 2022-01-20d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.2% | at 2021-01-20d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 3.8% | 2024-01-21 → 2025-01-20 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.6% | 2023-01-21 → 2024-01-20 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.4% | 2022-01-21 → 2023-01-20d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.8% | 2021-01-21 → 2022-01-20d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.1% | 2020-01-21 → 2021-01-20d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 33,137,000 | at 2025-01-20 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 16,568,000 | at 2024-01-20 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 16,568,000 | at 2023-01-20d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 16,568,000 | at 2022-01-20d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 16,568,000 | at 2021-01-20d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 51 | at 2025-01-20 | Standalone | Number of employees |
| Employees | 39 | at 2024-01-20 | Standalone | Number of employees |
| Employees | 26 | at 2023-01-20d | Standalone | Number of employees |
| Employees | 23 | at 2022-01-20d | Standalone | Number of employees |
| Employees | 19 | at 2021-01-20d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 95
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-01-21 → 2025-01-20 | ¥597m |
| Reconciling Itemsreconciling | depreciation | 2024-01-21 → 2025-01-20 | ¥796m |
| Reconciling Itemsreconciling | revenue | 2024-01-21 → 2025-01-20 | −¥378m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-21 → 2025-01-20 | −¥378m |
| Reconciling Itemsreconciling | segment assets | at 2025-01-20 | ¥34.5bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-21 → 2025-01-20 | −¥2.1bn |
| Domestic Beverage Businessreportable segment | capex | 2024-01-21 → 2025-01-20 | ¥7.1bn |
| Domestic Beverage Businessreportable segment | depreciation | 2024-01-21 → 2025-01-20 | ¥5.6bn |
| Domestic Beverage Businessreportable segment | employees | at 2025-01-20 | 3676 pure |
| Domestic Beverage Businessreportable segment | revenue | 2024-01-21 → 2025-01-20 | ¥147.5bn |
| Domestic Beverage Businessreportable segment | revenue external | 2024-01-21 → 2025-01-20 | ¥147.4bn |
| Domestic Beverage Businessreportable segment | revenue intersegment | 2024-01-21 → 2025-01-20 | ¥86m |
| Domestic Beverage Businessreportable segment | segment assets | at 2025-01-20 | ¥74.8bn |
| Domestic Beverage Businessreportable segment | segment profit | 2024-01-21 → 2025-01-20 | ¥986m |
| Dy Do Pharmareportable segment | capex | 2024-01-21 → 2025-01-20 | ¥382m |
| Dy Do Pharmareportable segment | depreciation | 2024-01-21 → 2025-01-20 | ¥21m |
| Dy Do Pharmareportable segment | employees | at 2025-01-20 | 12 pure |
| Dy Do Pharmareportable segment | revenue | 2024-01-21 → 2025-01-20 | ¥8m |
| Dy Do Pharmareportable segment | revenue external | 2024-01-21 → 2025-01-20 | ¥8m |
| Dy Do Pharmareportable segment | segment assets | at 2025-01-20 | ¥780m |
| Dy Do Pharmareportable segment | segment profit | 2024-01-21 → 2025-01-20 | −¥621m |
| Food Businessreportable segment | capex | 2024-01-21 → 2025-01-20 | ¥1.2bn |
| Food Businessreportable segment | depreciation | 2024-01-21 → 2025-01-20 | ¥834m |
| Food Businessreportable segment | employees | at 2025-01-20 | 309 pure |
| Food Businessreportable segment | revenue | 2024-01-21 → 2025-01-20 | ¥20.7bn |
| Food Businessreportable segment | revenue external | 2024-01-21 → 2025-01-20 | ¥20.6bn |
| Food Businessreportable segment | revenue intersegment | 2024-01-21 → 2025-01-20 | ¥7m |
| Food Businessreportable segment | segment assets | at 2025-01-20 | ¥21.0bn |
| Food Businessreportable segment | segment profit | 2024-01-21 → 2025-01-20 | ¥1.2bn |
| International Beverage Businessreportable segment | capex | 2024-01-21 → 2025-01-20 | ¥9.0bn |
| International Beverage Businessreportable segment | depreciation | 2024-01-21 → 2025-01-20 | ¥1.9bn |
| International Beverage Businessreportable segment | employees | at 2025-01-20 | 1148 pure |
| International Beverage Businessreportable segment | revenue | 2024-01-21 → 2025-01-20 | ¥56.3bn |
| International Beverage Businessreportable segment | revenue external | 2024-01-21 → 2025-01-20 | ¥56.3bn |
| International Beverage Businessreportable segment | segment assets | at 2025-01-20 | ¥37.5bn |
| International Beverage Businessreportable segment | segment profit | 2024-01-21 → 2025-01-20 | ¥5.1bn |
| Pharmaceutical Related Businessreportable segment | capex | 2024-01-21 → 2025-01-20 | ¥576m |
| Pharmaceutical Related Businessreportable segment | depreciation | 2024-01-21 → 2025-01-20 | ¥1.4bn |
| Pharmaceutical Related Businessreportable segment | employees | at 2025-01-20 | 359 pure |
| Pharmaceutical Related Businessreportable segment | revenue | 2024-01-21 → 2025-01-20 | ¥13.1bn |
| Pharmaceutical Related Businessreportable segment | revenue external | 2024-01-21 → 2025-01-20 | ¥12.8bn |
| Pharmaceutical Related Businessreportable segment | revenue intersegment | 2024-01-21 → 2025-01-20 | ¥284m |
| Pharmaceutical Related Businessreportable segment | segment assets | at 2025-01-20 | ¥16.6bn |
| Pharmaceutical Related Businessreportable segment | segment profit | 2024-01-21 → 2025-01-20 | ¥277m |
| —segment total | capex | 2024-01-21 → 2025-01-20 | ¥18.2bn |
| —segment total | depreciation | 2024-01-21 → 2025-01-20 | ¥9.7bn |
| —segment total | revenue | 2024-01-21 → 2025-01-20 | ¥237.6bn |
| —segment total | revenue external | 2024-01-21 → 2025-01-20 | ¥237.2bn |
| —segment total | revenue intersegment | 2024-01-21 → 2025-01-20 | ¥378m |
| —segment total | segment assets | at 2025-01-20 | ¥150.8bn |
| —segment total | segment profit | 2024-01-21 → 2025-01-20 | ¥6.9bn |
| Reconciling Itemsreconciling | capex | 2023-01-21 → 2024-01-20 | ¥926m |
| Reconciling Itemsreconciling | depreciation | 2023-01-21 → 2024-01-20 | ¥793m |
| Reconciling Itemsreconciling | revenue | 2023-01-21 → 2024-01-20 | −¥366m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-21 → 2024-01-20 | −¥366m |
| Reconciling Itemsreconciling | segment assets | at 2024-01-20 | ¥44.8bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-21 → 2024-01-20 | −¥2.2bn |
| Domestic Beverage Businessreportable segment | capex | 2023-01-21 → 2024-01-20 | ¥9.4bn |
| Domestic Beverage Businessreportable segment | depreciation | 2023-01-21 → 2024-01-20 | ¥5.1bn |
| Domestic Beverage Businessreportable segment | revenue | 2023-01-21 → 2024-01-20 | ¥153.6bn |
| Domestic Beverage Businessreportable segment | revenue external | 2023-01-21 → 2024-01-20 | ¥153.6bn |
| Domestic Beverage Businessreportable segment | revenue intersegment | 2023-01-21 → 2024-01-20 | ¥26m |
| Domestic Beverage Businessreportable segment | segment assets | at 2024-01-20 | ¥74.7bn |
| Domestic Beverage Businessreportable segment | segment profit | 2023-01-21 → 2024-01-20 | ¥4.3bn |
| Dy Do Pharmareportable segment | capex | 2023-01-21 → 2024-01-20 | ¥57m |
| Dy Do Pharmareportable segment | depreciation | 2023-01-21 → 2024-01-20 | ¥9m |
| Dy Do Pharmareportable segment | segment assets | at 2024-01-20 | ¥381m |
| Dy Do Pharmareportable segment | segment profit | 2023-01-21 → 2024-01-20 | −¥796m |
| Food Businessreportable segment | capex | 2023-01-21 → 2024-01-20 | ¥638m |
| Food Businessreportable segment | depreciation | 2023-01-21 → 2024-01-20 | ¥848m |
| Food Businessreportable segment | revenue | 2023-01-21 → 2024-01-20 | ¥20.7bn |
| Food Businessreportable segment | revenue external | 2023-01-21 → 2024-01-20 | ¥20.7bn |
| Food Businessreportable segment | revenue intersegment | 2023-01-21 → 2024-01-20 | ¥7m |
| Food Businessreportable segment | segment assets | at 2024-01-20 | ¥21.4bn |
| Food Businessreportable segment | segment profit | 2023-01-21 → 2024-01-20 | ¥993m |
| International Beverage Businessreportable segment | capex | 2023-01-21 → 2024-01-20 | ¥1.2bn |
| International Beverage Businessreportable segment | depreciation | 2023-01-21 → 2024-01-20 | ¥859m |
| International Beverage Businessreportable segment | revenue | 2023-01-21 → 2024-01-20 | ¥26.4bn |
| International Beverage Businessreportable segment | revenue external | 2023-01-21 → 2024-01-20 | ¥26.4bn |
| International Beverage Businessreportable segment | segment assets | at 2024-01-20 | ¥16.7bn |
| International Beverage Businessreportable segment | segment profit | 2023-01-21 → 2024-01-20 | ¥1.1bn |
| Pharmaceutical Related Businessreportable segment | capex | 2023-01-21 → 2024-01-20 | ¥483m |
| Pharmaceutical Related Businessreportable segment | depreciation | 2023-01-21 → 2024-01-20 | ¥1.2bn |
| Pharmaceutical Related Businessreportable segment | revenue | 2023-01-21 → 2024-01-20 | ¥13.0bn |
| Pharmaceutical Related Businessreportable segment | revenue external | 2023-01-21 → 2024-01-20 | ¥12.6bn |
| Pharmaceutical Related Businessreportable segment | revenue intersegment | 2023-01-21 → 2024-01-20 | ¥331m |
| Pharmaceutical Related Businessreportable segment | segment assets | at 2024-01-20 | ¥19.5bn |
| Pharmaceutical Related Businessreportable segment | segment profit | 2023-01-21 → 2024-01-20 | ¥367m |
| —segment total | capex | 2023-01-21 → 2024-01-20 | ¥11.7bn |
| —segment total | depreciation | 2023-01-21 → 2024-01-20 | ¥8.0bn |
| —segment total | revenue | 2023-01-21 → 2024-01-20 | ¥213.7bn |
| —segment total | revenue external | 2023-01-21 → 2024-01-20 | ¥213.4bn |
| —segment total | revenue intersegment | 2023-01-21 → 2024-01-20 | ¥366m |
| —segment total | segment assets | at 2024-01-20 | ¥132.7bn |
| —segment total | segment profit | 2023-01-21 → 2024-01-20 | ¥5.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,765
| Item | Context | Value | Unit |
|---|---|---|---|
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 16000000 | JPY |
| Base remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 16000000 | JPY |
| Performance linked bonus remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
| Restricted share awards remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
| Trust type stock compensation remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 1 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsMember | 24000000 | JPY |
| Base remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsMember | 24000000 | JPY |
| Performance linked bonus remuneration by category of directors and other officers | CurrentYearDuration_OutsideDirectorsMember | － | JPY |
| Restricted share awards remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsMember | － | JPY |
| Trust type stock compensation remuneration by category of directors and other officers | CurrentYearDuration_OutsideDirectorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsMember | 5 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideCorporateAuditorsMember | 18000000 | JPY |
| Base remuneration remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideCorporateAuditorsMember | 18000000 | JPY |
| Performance linked bonus remuneration by category of directors and other officers | CurrentYearDuration_OutsideCorporateAuditorsMember | － | JPY |
| Restricted share awards remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideCorporateAuditorsMember | － | JPY |
| Trust type stock compensation remuneration by category of directors and other officers | CurrentYearDuration_OutsideCorporateAuditorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideCorporateAuditorsMember | 4 | |
| Total amount of remuneration etc paid by group remuneration etc paid by group to each director or other officer | CurrentYearDuration_jpcrp030000-asr_E00424-000TakamatsuTomiyaMember | 176000000 | JPY |
| Number of issues shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 14 | |
| Carrying amount shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 127000000 | JPY |
| Number of issues shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 9 | |
| Carrying amount shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearInstant | 3765000000 | JPY |
| Number of issues whose number of shares increased shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Total acquisition cost for increased shares shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | JPY |
| Number of issues whose number of shares increased shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Total acquisition cost for increased shares shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | JPY |
| Number of issues whose number of shares decreased shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Total sale amount for decreased shares shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | JPY |
| Number of issues whose number of shares decreased shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | 2 | |
| Total sale amount for decreased shares shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | 3874000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | 544000 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row1Member | 544000 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | 1721000000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row1Member | 1115000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | 253000 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row2Member | 253000 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | 1242000000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row2Member | 1143000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | 132000 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row3Member | 132000 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | 302000000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row3Member | 305000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | 248755 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row4Member | 248755 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | 283000000 | JPY |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row4Member | 189000000 | JPY |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | 75000 | |
| Number of shares held details of specified investment equity securities held for purposes other than pure investment reporting company | Prior1YearInstant_Row5Member | 75000 | |
| Book value details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | 96000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |